These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 570505)

  • 1. Dopaminergic antagonism and catalepsy in the developing rat.
    Baez LA; Burt DK; Granneman J; Shanklin C
    Eur J Pharmacol; 1979 Feb; 54(1-2):15-20. PubMed ID: 570505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal development of dopaminergic and cholinergic catalepsy in the rat.
    Baez LA; Eskridge NK; Schein R
    Eur J Pharmacol; 1976 Mar; 36(1):155-62. PubMed ID: 944132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The striatal dopaminergic catalepsy mechanism is not necessary for the expression of pontine catalepsy produced by carbachol injections into the pontine reticular formation.
    Elazar Z; Peleg N; Paz M; Ring G
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):187-93. PubMed ID: 7477442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
    Banasikowski TJ; Beninger RJ
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex.
    Klockgether T; Schwarz M; Turski L; Sontag KH
    Exp Brain Res; 1988; 70(2):445-7. PubMed ID: 3384045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy.
    Sevak RJ; Koek W; France CP
    Eur J Pharmacol; 2005 Jul; 517(1-2):64-7. PubMed ID: 15975572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine modulation of haloperidol-induced catalepsy].
    Speciale C; Ferrara N; Sortino MA; Giammona G; Bernardini R; De Simone D; Marano P
    Boll Soc Ital Biol Sper; 1983 Jan; 59(1):51-7. PubMed ID: 6303368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol catalepsy consolidation in the rat as a model of neuromodulatory integration.
    Bazyan AS; Getsova VM; Orlova NV
    Neuroscience; 2000; 99(2):279-88. PubMed ID: 10938433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative importance of the dopaminergic system in haloperidol-catalepsy and the anticataleptic effect of antidepressants and methamphetamine in rats.
    Al-Khatib IM; Fujiwara M; Ueki S
    Pharmacol Biochem Behav; 1989 May; 33(1):93-7. PubMed ID: 2528750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kainic acid injections in the striatum alter the cataleptic and locomotor effects of drugs influencing dopaminergic and cholinergic systems.
    Sanberg PR; Pisa M; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(4):347-57. PubMed ID: 7197631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of age and isolation on the evolution of catalepsy during chronic haloperidol treatment.
    Frussa-Filho R; Otoboni JR; Uema FT; Palermo-Neto J
    Braz J Med Biol Res; 1992; 25(9):925-8. PubMed ID: 1342840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lesions of raphe nuclei on the cataleptic action of neuroleptics.
    Przewłocka B; Kukułka L; Tatarczyńska E
    Pol J Pharmacol Pharm; 1977; 29(6):581-9. PubMed ID: 23522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice.
    Viyoch J; Ohdo S; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2001 Sep; 298(3):964-9. PubMed ID: 11504791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy.
    Balsara JJ; Jadhav JH; Chandorkar AG
    Psychopharmacology (Berl); 1979 Mar; 62(1):67-9. PubMed ID: 108749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On filo- and ontogenetic development of dopaminergic regylation of wakefulness-sleep cycle in vertabrates].
    Oganesian GA; Aristakesian EA; Romanova IV; Vataev SI; Kuzik VV
    Ross Fiziol Zh Im I M Sechenova; 2012 Oct; 98(10):1213-27. PubMed ID: 23401916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents.
    Gentzel RC; Toolan D; Roberts R; Koser AJ; Kandebo M; Hershey J; Renger JJ; Uslaner J; Smith SM
    Neuropharmacology; 2015 Dec; 99():256-63. PubMed ID: 26044638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic-dopaminergic interactions in experimental catalepsy.
    Klemm WR
    Psychopharmacology (Berl); 1983; 81(1):24-7. PubMed ID: 6415727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of spiny I activity in striatum after development of context-dependent sensitization of catalepsy in rats.
    Frank ST; Schmidt WJ
    Neurosci Lett; 2004 Jan; 354(1):10-3. PubMed ID: 14698470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.